A possible mechanism of the antitumor activity of gold nanoparticles (GNPs) with a surface modified by carbohydrate residues tropic for tumor cell membrane lectins was studied using human colon adenocarcinoma (Caco-2) cells. Caco-2 cells were incubated for 2 and 8 h with GNP solutions. GNPs reduced the level of SH groups during a 2-hour incubation with the cells by an average of 20 times (p < 0.05); during an 8-hour incubation, by an average of 10 times (p < 0.05). The transmembrane potential of mitochondria was observed to decrease on average up to 58% (p < 0.05) after incubation for 8 h with GNP with a surface modified by fucose and lactose. GNPs modified with fucose residues increased the malondialdehyde (MDA) level by 1.5 times (p < 0.05) and the amount of proapoptotic transcription factor p53, by >2.5 times (p < 0.05) after incubation for 8 h. Thus, GNPs with surfaces modified by fucose, lactose, and galactose residues had a cytotoxic effect on Caco-2 cells, activating lipid peroxidation (Au-Fuc) and possibly initiating one of the apoptosis pathways through stimulation of the transcription factor p53 and decreasing the transmembrane potential of mitochondria.
Similar content being viewed by others
References
P. D. Haria, A. D. Baheti, D. Palsetia, et al., Clin. Radiol., 76(12), 908 – 915 (2021); doi: https://doi.org/10.1016/j.crad.2021.07.016.
A. Yu. Ershov, M. A. Kopanitsa, N. V. Korotkova, et al., Nauka Molodykh (Eruditio Juventum), 7, No. 2, 247 – 254 (2019); doi: https://doi.org/10.23888/Hmj201972247-254.
E. V. Raguzin, M. A. Yudin, N. G. Glushenko, et al., Ross. Med.-Biol. Vestn. im. Akad. I. P. Pavlova, 3(3), 397 – 410 (2022); doi: https://doi.org/10.17816/PAVLOVJ104787.
S. Ahn, I. H. Lee, S. Kang, et al., Adv. Healthcare Mater., 8, 1194 – 1199 (2014); doi: https://doi.org/10.1002/adhm.201300597.
I. V. Chernykh, M. A. Kopanitsa, A. V. Shchul’kin, et al., Khim.-farm. Zh., 55(9), 34 – 42 (2021); doi: https://doi.org/10.30906/0023-1134-2021-55-9-34-42.
A. Yu. Ershov, A. A. Martynenkov, I. V. Lagoda, et al., Zh. Obshch. Khim., 91(2), 260 – 268 (2021); doi: https://doi.org/10.31857/S0044460X21020098.
E. Catanzaro, C. Calcabrini, A. Bishayee, et al., Mar. Drugs, 18(1), 11 (2020); doi: https://doi.org/10.3390/md18010011.
K. Ono, Y. Sanada, Y. Kimura, et al., Biomater. Sci., 8(2), 577 – 585 (2020); doi: https://doi.org/10.1039/c9bm01758e; PMID: 31872195.
I. V. Chernykh, M. A. Kopanitsa, A. V. Shchul’kin, et al., Ross. Med.-Biol. Vestn. im. Akad. I. P. Pavlova, 31(2), 255 – 264 (2023).
A. Babaei, S. M. Mousavi, M. Ghasemi, et al., Life Sci., 284, 119652 (2021); doi: https://doi.org/10.1016/j.lfs.2021.119652.
A. V. Shchul’kin, Yu. V. Abalenikhina, P. D. Erokhina, et al., Eksp. Klin. Farmakol., 84(11), 9 – 12 (2021); doi: https://doi.org/10.30906/0869-2092-2021-84-11-9-12.
S. Blondy, V. David, M. Verdier, et al., Cancer Sci., 111(9), 3142 – 3154 (2020); doi: https://doi.org/10.1111/cas.14532.
G. L. Ellman, Arch. Biochem. Biophys., 82, 70 – 77 (1959); doi: https://doi.org/10.1016/0003-9861(59)90090-6.
M. M. Bradford, Anal. Biochem., 72(1 – 2), 248 – 254 (1976); doi: https://doi.org/10.1006/abio.1976.9999.
M. Enea, E. Pereira, M. Peixoto de Almeida, et al., Nanomaterials (Basel), 10(5), 995 (2020); doi: https://doi.org/10.3390/nano10050995.
H. Khan, H. R. Mirzaei, A. Amiri, et al., Semin. Cancer Biol., 69(2), 24 – 42 (2019); doi: https://doi.org/10.1016/j.semcancer.2019.12.004.
K. E. Ibrahim, M. G. Al-Mutary, A. O. Bakhiet, et al., Molecules, 23(8), 1848 (2018); doi: https://doi.org/10.3390/molecules23081848.
T. Osuga, R. Takimoto, M. Ono, et al., J. Natl. Cancer. Inst., 108(9), 1 – 9 (2016); doi: https://doi.org/10.1093/jnci/djw038.
T. V. Denisenko, A. D. Pivnyuk, and B. Zhivotovsky, Cancers (Basel), 10(5), 148 (2018); doi: https://doi.org/10.3390/cancers10050148.
C. D. Anuradhaa, S. Kannoa, and S. Hirano, Free Radical Biol. Med., 31(3), 367 – 373 (2001); doi: https://doi.org/10.1016/S0891-5849(01)00591-3.
G. T. Prince, M. C. Cameron, R. Fathi, et al., Int. J. Dermatol., 57(10), 1259 – 1264 (2018); doi: https://doi.org/10.1111/ijd.14106.
A. A. Date, J. Hanes, and L. M. Ensign, J. Controlled Release, 240, 504 – 526 (2016); doi: https://doi.org/10.1016/j.jconrel.2016.06.016.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 9, pp. 16 – 20, September, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chernykh, I.V., Kopanitsa, M.A., Shchulkin, A.V. et al. Mechanism of Antitumor Activity of Gold Glyconanoparticles Against Human Colon Adenocarcinoma Cells. Pharm Chem J 57, 1362–1366 (2023). https://doi.org/10.1007/s11094-023-02998-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02998-8